戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1 sions were noted, and their apparent diffusion values (ADC) were calculated.
2                                    Absorbed radiation doses were calculated.
3 ) PUFAs measured in second-trimester plasma; n-6/n-3 ratios were calculated.
4 d the percentage of the realization of mineral requirements were calculated.
5 tive factors for mortality from the years 2007 through 2014 were calculated.
6 dardized detection rates and age-adjusted odds ratios (ORs) were calculated.
7 rate constant, activation energy, and temperature quotient) were calculated.
8                 Medicare payments for each surgical episode were calculated.
9                              Summary descriptive statistics were calculated.
10 r concentrations and percentages within each lipid fraction were calculated.
11 auses, the years of life lost (YLLs) due to premature death were calculated.
12 sel density (mSVC_VD), and foveal avascular zone (FAZ) area were calculated.
13 and genetic risk scores (GRSs) for each of those 3 pathways were calculated.
14 biopsies performed percentage, sensitivity, and specificity were calculated.
15 ed, and relative SI changes from baseline to interval scans were calculated.
16 cteristic (ROC) curves; Area Under Curve (AUC) and accuracy were calculated and compared using Wilcoxon signed rank test
17 y infection and those requiring further inpatient treatment were calculated, and 95% binomial proportion CIs were obtaine
18 s of cobalt in cobalamin and cobalt for HPLC-ICP-OES system were calculated as 0.07 mg/kg (as Co) and 0.06 mg/kg, respect
19  limit of detection (LOD) and limit of quantification (LOQ) were calculated as 0.13 mug L(-1)and 0.41 mug L(-1) respectiv
20                                           Odds ratios (ORs) were calculated as part of the logistic regression analysis.
21 composite) using z-scores for neuropsychological tests that were calculated based on scores for participants with normal
22   Mortality was estimated first and the incidence and DALYs were calculated based on the estimated mortality values.
23                                 Standardized relative risks were calculated bidirectionally for any SPC after skin cancer
24                                         The estimated rates were calculated by age, sex and according to the Socio-Demogr
25                                 Hazard ratios for mortality were calculated by using Cox regression models with emphysema
26 S treatment response (LR-TR) category (viable or nonviable) were calculated by using generalized mixed-effects models to
27         Rate ratios (RR) and 95% confidence intervals (CIs) were calculated comparing CVD rates in the 2 d following the
28 Overall % mean scores across AGREE II and AGREE-REX domains were calculated for each guideline.
29         The temporal dynamics of spike spatial distribution were calculated for each patient and the effects of sleep and
30                              Rasch-calibrated domain scores were calculated for each questionnaire domain and compared be
31 ate (CDR), recall rate, and positive predictive value (PPV) were calculated for each reader, for both real-life screening
32                                Indices of network integrity were calculated for each subject, network, and imaging modali
33                                             Infection rates were calculated for each woman-year in care with testing.
34                                    Widths of tissue bridges were calculated from midsagittal T2-weighted images and compa
35                                             PREMM(5) scores were calculated from personal/family cancer history.
36              Intravoxel incoherent motion (IVIM) parameters were calculated from resulting volumes.
37                                 Intraocular pressure values were calculated from the deep learning-predicted tonometer an
38   Anatomic structures were segmented, and median R2* values were calculated in the neocortex and cortical lobes, basal ga
39 or the radiologists and artificial intelligence (AI) system were calculated on a subset of 100 random internal and 100 ex
40                                     All incidence estimates were calculated per 100 000 population and averaged across th
41  were applied to both Medicare and commercial claims, rates were calculated per 1000 enrollees, and trends were reported
42 the inferior temporal quadrant/superior nasal quadrant (R2) were calculated (R1ET, R1BLT; R2ET, R2BLT).
43                The casewise concordance rates for mutations were calculated to assess genetic predisposition.
44                              From the calibration plot LODs were calculated to be 0.032 ug L(-1) (Cd(II)) and 0.015 ug L(
45 for in-hospital mortality, and the average marginal effects were calculated to compare the cost of hospitalization with a
46             Incremental Z-score values between -2.5 and 2.5 were calculated to establish upper and lower limits of normal
47 e gearing mechanism, and the activation barriers to gearing were calculated using density functional theory.
48 ensor signal was determined and then TVC values (CFU/cm(2)) were calculated using the calibration equation.
49 ets and the Alternate Healthy Eating Index 2010 (AHEI-2010) were calculated using validated food-frequency questionnaires
50 standard mean differences of 95% confidence intervals (CIs) were calculated with the random-effects model.